Spiecker, M <br/><br/>
Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.  [electronic resource] 

 -  Thrombosis research  Jun 1993 
 - 405-15 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/0049-3848(93)90082-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenylyl Cyclase Inhibitors<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Blood Pressure--drug effects<br/>Drug Synergism<br/>Enzyme Activation--drug effects<br/>Guanylate Cyclase--metabolism<br/>Iloprost--pharmacology<br/>Male<br/>Molsidomine--analogs & derivatives<br/>Nitric Oxide--metabolism<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Signal Transduction--drug effects